Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Application US20180193395
Engen Medical Corporation

Use Of American Ginseng To Counteract Cannabis-induced Intoxication

A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide.

Much More than Average Length Specification


1 Independent Claims

  • Claim CLM-00001. 1. A composition of Panax quinquefolius comprising a dosage in an amount effective for the attenuation of Cannabis-induced dysphoria.
  • Claim CLM-00005. 5. A method for the attenuation of Cannabis-induced dysphoria comprising administering a therapeutically effective amount of a composition containing Panax quinquefolius where the amount of Panax quinquefolius is 300 mg.


View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >



Patent Matrix® Search


USPTO Patent Document Number